Zhang et al. reported that irinotecan-resistant LoVo cells showed the dysregulation of EMT markers (E-cadherin downregulated; vimentin and N-cadherin expressions upregulated), suggesting that EMT was associated with the development of drug resistance in CRC cells [90]. The gene discussed is CDH1; the disease is colorectal carcinoma.